Short interest in Viracta Therapeutics Inc (NASDAQ:VIRX) decreased during the last reporting period, falling from 609.89K to 246.04K. This put 0.79% of the company's publicly available shares short.

Short interest for Viracta Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Viracta Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 2.74M shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.